Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Free Cash Flow Generation Index
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Free Cash Flow Generation Index of 0.23x as of December 2024. Free cash flow of CN¥20.78 Million represents 0% of operating cash flow (CN¥89.33 Million). Read Guangdong Taienkang Pharmaceutical Co. L balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guangdong Taienkang Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2019–2024)
Historical FCF Generation Index trend for Guangdong Taienkang Pharmaceutical Co. Ltd across 6 annual periods. Explore 301263 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2024)
Year-by-year Free Cash Flow Generation Index for Guangdong Taienkang Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see Guangdong Taienkang Pharmaceutical Co. L (301263) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | CN¥20.78 Million | CN¥89.33 Million | CN¥68.55 Million | ▲ +120.4% |
| 2023 | -1.14x | CN¥-106.48 Million | CN¥93.53 Million | CN¥200.01 Million | ▼ -387.5% |
| 2022 | 0.40x | CN¥58.94 Million | CN¥148.81 Million | CN¥89.88 Million | ▼ -36.9% |
| 2021 | 0.63x | CN¥75.38 Million | CN¥120.02 Million | CN¥44.65 Million | ▲ +143.2% |
| 2020 | 0.26x | CN¥32.41 Million | CN¥125.53 Million | CN¥93.12 Million | ▼ -70.8% |
| 2019 | 0.88x | CN¥66.61 Million | CN¥75.44 Million | CN¥8.83 Million | — |